(Q44813870)

6 December 2017

title

Inter-digestive and post-prandial antro-pyloro-duodenal motor activity in humans: effect of 5-hydroxytryptamine 1 receptor agonism (English)

1 reference

6 December 2017

Calvert EL

1

1 reference

6 December 2017

Whorwell PJ

series ordinal

2

1 reference

6 December 2017

Houghton LA

series ordinal

3

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

Alimentary Pharmacology & Therapeutics

6 December 2017

published in

1 reference

6 December 2017

volume

19

1 reference

6 December 2017

issue

7

1 reference

6 December 2017

page(s)

805-815

1 reference

5-Hydroxytryptamine and functional bowel disorders

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

Role of nitric oxide in the gastric accommodation reflex and in meal induced satiety in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

Effects of 5-HT(3) antagonism on postprandial gastric volume and symptoms in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

The proximal stomach and postprandial symptoms in functional dyspeptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

In vivo effects of sumatriptan (GR 43175) on extracellular levels of 5-HT in the guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

Impaired osmotic sensation in mice lacking TRPV4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

Is chest pain after sumatriptan oesophageal in origin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

Effect of sumatriptan, a 5HT1 agonist, on the frequency of transient lower esophageal sphincter relaxations and gastroesophageal reflux in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

Gastrin biosynthesis in the antrum of patients with pernicious anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

Relationship of the motor activity of the antrum, pylorus, and duodenum to gastric emptying of a solid-liquid mixed meal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

Gastroduodenal motility during the delayed gastric emptying induced by cold stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

Somatostatin and the interdigestive migrating motor complex in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

Mechanics of pulsatile transpyloric flow in the pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

Altered oesophageal motility following the administration of the 5-HT1 agonist, sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

Twin studies in medical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01901.X

10.1111/J.1365-2036.2004.01901.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference